<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35703301</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>09</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1532-0987</ISSN><JournalIssue CitedMedium="Internet"><Volume>41</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>The Pediatric infectious disease journal</Title><ISOAbbreviation>Pediatr Infect Dis J</ISOAbbreviation></Journal><ArticleTitle>Reassessing the Performance of the "Step-By-Step" Approach to Febrile Infants 90 Days of Age and Younger in the Context of the COVID-19 Pandemic: A Multicentric Retrospective Study.</ArticleTitle><Pagination><StartPage>e365</StartPage><EndPage>e368</EndPage><MedlinePgn>e365-e368</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/INF.0000000000003614</ELocationID><Abstract><AbstractText Label="BACKGROUND">Infants with COVID-19 can often present with fever without source, which is a challenging situation in infants &lt;90 days old. The "step-by-step" algorithm has been proposed to identify children at high risk of bacterial infection. In the context of the COVID-19 pandemic, we aimed to reassess the diagnostic performance of this algorithm.</AbstractText><AbstractText Label="METHODS">We performed a multicentric retrospective study in 3 French pediatric emergency departments between 2018 and 2020. We applied the "step-by-step" algorithm to 4 clinical entities: COVID-19, febrile urinary tract infections (FUTI), invasive bacterial infection (IBI), and enterovirus infections. The main outcome was the proportion of infants classified at high risk (ill-appearing, ≤21 days old, with leukocyturia or procalcitonin level ≥0.5 ng/mL).</AbstractText><AbstractText Label="RESULTS">Among the 199 infants included, 40 had isolated COVID-19, 25 had IBI, 60 had FUTI, and 74 had enterovirus infection. All but 1 infant with bacterial infection were classified at high risk (96% for IBI and 100% for FUTI) as well as 95% with enterovirus and 82% with COVID-19. Infants with COVID-19 were classified at high risk because an ill-appearance (72%), an age ≤21 days (27%), or leukocyturia (19%). All these infants had procalcitonin values &lt;0.5 ng/mL and only 1 had C-reactive protein level &gt;20 mg/L.</AbstractText><AbstractText Label="CONCLUSIONS">The "step-by-step" algorithm remains effective to identify infants with bacterial infection but misclassifies most infants with COVID-19 as at high risk of bacterial infection leading to unnecessary cares. An updated algorithm based adding viral testing may be needed to discriminate fever related to isolated COVID-19 in infants &lt;90 days old.</AbstractText><CopyrightInformation>Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rybak</LastName><ForeName>Alexis</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0002-2898-3710</Identifier><AffiliationInfo><Affiliation>From the Pediatric Emergency Department, Robert Debré University Hospital, Université de Paris, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aupiais</LastName><ForeName>Camille</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>INSERM, Unité Mixte de Recherche 1123 Epidémiologie Clinique et Évaluation Économique Appliquées aux Populations Vulnérables (ECEVE), Université de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cotillon</LastName><ForeName>Marie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Louis Mourier University Hospital, Université de Paris, Assistance Publique-Hôpitaux de Paris, Colombes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Basmaci</LastName><ForeName>Romain</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Louis Mourier University Hospital, Université de Paris, Assistance Publique-Hôpitaux de Paris, Colombes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Pontual</LastName><ForeName>Loïc</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Jean Verdier University Hospital, Assistance Publique-Hôpitaux de Paris, Université Sorbonne Paris Nord, Bondy, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonacorsi</LastName><ForeName>Stéphane</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>INSERM, Unité Mixte de Recherche 1137 Infection-Antimicrobials-Modelling-Evolution (IAME), Université de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mariani</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Robert Debré University Hospital, Université de Paris, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Landraud</LastName><ForeName>Luce</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Microbiology, Louis Mourier University Hospital, Université de Paris, Assistance Publique-Hôpitaux de Paris, Colombes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brichler</LastName><ForeName>Ségolène</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Paris-Seine-Saint-Denis University Hospitals, Université Sorbonne Paris Nord, Assistance Publique-Hôpitaux de Paris, Bobigny, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Poilane</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Clinical Microbiology, Paris-Seine-Saint-Denis University Hospitals, Université Sorbonne Paris Nord, Assistance Publique-Hôpitaux de Paris, Bobigny, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ouldali</LastName><ForeName>Naïm</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Association Clinique et Thérapeutique Infantile du Val-de-Marne (ACTIV), Créteil, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Titomanlio</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>From the Pediatric Emergency Department, Robert Debré University Hospital, Université de Paris, Assistance Publique-Hôpitaux de Paris, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Pediatr Infect Dis J</MedlineTA><NlmUniqueID>8701858</NlmUniqueID><ISSNLinking>0891-3668</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000077740">Procalcitonin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D001424" MajorTopicYN="Y">Bacterial Infections</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005334" MajorTopicYN="N">Fever</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000077740" MajorTopicYN="N">Procalcitonin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014552" MajorTopicYN="Y">Urinary Tract Infections</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors have no funding or conflicts of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>16</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>15</Day><Hour>6</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>6</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35703301</ArticleId><ArticleId IdType="pmc">PMC9359674</ArticleId><ArticleId IdType="doi">10.1097/INF.0000000000003614</ArticleId><ArticleId IdType="pii">00006454-202209000-00018</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Milcent K, Faesch S, Gras-Le Guen C, et al. . Use of procalcitonin assays to predict serious bacterial infection in young febrile infants. JAMA Pediatr. 2016;170:62–69.</Citation><ArticleIdList><ArticleId IdType="pubmed">26595253</ArticleId></ArticleIdList></Reference><Reference><Citation>Mintegi S, Bressan S, Gomez B, et al. . Accuracy of a sequential approach to identify young febrile infants at low risk for invasive bacterial infection. Emerg Med J. 2014;31(e1):e19–e24.</Citation><ArticleIdList><ArticleId IdType="pubmed">23851127</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantell RH, Roberts KB, Adams WG, et al. ; Subcommittee on Febrile Infants. Evaluation and management of well-appearing febrile infants 8 to 60 days old. Pediatrics. 2021;148:e2021052228.</Citation><ArticleIdList><ArticleId IdType="pubmed">34281996</ArticleId></ArticleIdList></Reference><Reference><Citation>Hubert G, Launay E, Feildel Fournial C, et al. . Assessment of the impact of a new sequential approach to antimicrobial use in young febrile children in the emergency department (DIAFEVERCHILD): a French prospective multicentric controlled, open, cluster-randomised, parallel-group study protocol. BMJ Open. 2020;10:e034828.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7430445</ArticleId><ArticleId IdType="pubmed">32792425</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez B, Mintegi S, Bressan S, et al. ; European Group for Validation of the Step-by-Step Approach. Validation of the “Step-by-Step” approach in the management of young febrile infants. Pediatrics. 2016;138:e20154381.</Citation><ArticleIdList><ArticleId IdType="pubmed">27382134</ArticleId></ArticleIdList></Reference><Reference><Citation>de Crom SC, van Furth MA, Peeters MF, et al. . Characteristics of pediatric patients with enterovirus meningitis and no cerebral fluid pleocytosis. Eur J Pediatr. 2012;171:795–800.</Citation><ArticleIdList><ArticleId IdType="pubmed">22102153</ArticleId></ArticleIdList></Reference><Reference><Citation>de Crom SC, Rossen JW, van Furth AM, et al. . Enterovirus and parechovirus infection in children: a brief overview. Eur J Pediatr. 2016;175:1023–1029.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4930465</ArticleId><ArticleId IdType="pubmed">27156106</ArticleId></ArticleIdList></Reference><Reference><Citation>Mark EG, Golden WC, Gilmore MM, et al. . Community-onset severe acute respiratory syndrome coronavirus 2 infection in young infants: a systematic review. J Pediatr. 2021;228:94–100.e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7477627</ArticleId><ArticleId IdType="pubmed">32910943</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellini T, Rotulo GA, Caruggi S, et al. . Characteristics of COVID-19 patients up to 6 months of age admitted to a paediatric emergency department. Acta Paediatr. 2022;111:272–274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8653029</ArticleId><ArticleId IdType="pubmed">34704279</ArticleId></ArticleIdList></Reference><Reference><Citation>Dieckmann RA, Brownstein D, Gausche-Hill M. The pediatric assessment triangle: a novel approach for the rapid evaluation of children. Pediatr Emerg Care. 2010;26:312–315.</Citation><ArticleIdList><ArticleId IdType="pubmed">20386420</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelman A, Hill J, Yajima M. Why we (Usually) don’t have to worry about multiple comparisons. J Res Educ Eff. 2012;5:189–211.</Citation></Reference><Reference><Citation>Veneti L, Boas H, Brathen Kristoffersen A, et al. . Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022. Euro Surveill. 2022;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8796289</ArticleId><ArticleId IdType="pubmed">35086614</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>